Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease

NCT07685938 is registered in ClinicalTrials.gov with UNC Lineberger Comprehensive Cancer Center as lead sponsor.

NCT NCT07685938
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07685938 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease
Lead sponsor
UNC Lineberger Comprehensive Cancer Center
Phase
Phase 2
Overall status
Recruiting
Start date
August 12, 2026
Completion date
February 28, 2029
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, chest wall tumor, esophageal cancer, lung cancer, mediastinal cancers, spinal tumor, spine metastases, thoracic cancer, thoracic neoplasms